CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Phosphothioate oligodeoxynucleotides inhibit Plasmodium sporozoite gliding motility
Authors
Ana Rita França
Eicke Latz
+4 more
Peter Liehl
Maria M. Mota
Miguel Prudêncio
Anna Zaidman-Rémy
Publication date
1 April 2010
Publisher
'Wiley'
Doi
Cite
Abstract
© 2009 The Authors. Journal compilation © 2009 Blackwell Publishing LtdPlasmodium sporozoites, transmitted to the mammalian host through a mosquito bite, travel to the liver, where they invade hepatocytes, and develop into a form that is then able to infect red blood cells. In spite of the importance of innate immunity in controlling microbial infections, almost nothing is known about its role during the liver stage of a malaria infection. Here, we tested whether synthetic CpG phosphothioate (PS) oligodeoxynucleotides (ODNs), which bind to Toll-like receptor 9 (Tlr9), could have a protective effect on Plasmodium berghei infection in hepatocytes. Surprisingly, CpG PS-ODNs potently impair P. berghei infection in hepatoma cell lines independently of Tlr9 activation. Indeed, not only CpG but also non-CpG PS-ODNs, which do not activate Tlr9, decreased parasite infection. Moreover, the ability of PS-ODNs to impair infection was not due to an effect on the host but rather on the parasite itself. In fact, CpG PS-ODNs, as well as non-CpG PS-ODNs, impair parasite gliding motility. Furthermore, our analysis reveals that PS-ODNs inhibit parasite migration and invasion due to their negative charge, whereas development inside hepatocytes is undisturbed. Altogether, PS-ODNs might represent a new class of prophylactic anti-malaria agents, which hamper hepatocyte entry by Plasmodium sporozoites.This work was funded by Fundação para a Ciência e Tecnologia (FCT) of the Portuguese Ministry of Science (Grant PTDC/BIA-MIC/72211/2006) and European Science Foundation (EURYI). P.L. was supported by Fondation pour la Recherche Médicale and FCT. A.R.F. and A.Z.R. were supported by FCT fellowships. M.M.M. is a Howard Hughes Medical Institute International Scholar and a BioMalPar-affiliated member.info:eu-repo/semantics/publishedVersio
Similar works
Full text
Available Versions
Universidade de Lisboa: Repositório.UL
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:repositorio.ul.pt:10451/48...
Last time updated on 15/09/2021